Patents not ‘limiting factor’ for vaccine production: BioNTech
German firm BioNTech said Thursday that patent protection for COVID-19 vaccines is not holding back production or supply of the jabs that it developed with Pfizer.
- Next story The Division getting a standalone free-to-play game called Heartland
- Previous story Mayo Clinic Minute: Lifestyle changes to manage menopause symptoms
Explore more
- Belgium warns intensive care units buckling
Belgium’s health ministry warned Friday intensive care units are struggling to cope... - India reports record 4,529 daily COVID-19 deaths
India on Wednesday reported a record 4,529 coronavirus deaths in a single... - Fujifilm’s no-frills Instax Mini 40 camera makes prints quick
Fujifilm has added another camera to its Instax line-up, with the Instax... - How to recall an email in Outlook
Writing angry emails can be cathartic, but it’s best not to send... - Covid Vaccine Lag in U.S. South May Lead to Summer Wave of Infections
In 15 states, including Arkansas, the Carolinas, Georgia and Louisiana, about half... - Walmart is practically giving away this ultra-slim Gateway laptop
Walmart is offering a crazy deal on the Gateway GWTN156-1BL Ultra Slim... - These Asian American health care workers are fighting two viruses: Covid and hate
Health care workers are on the front lines of the coronavirus pandemic,... - EU’s COVID health pass to be operational in June
The EU is “fully on track” to ensure all its citizens and... - Candidates Escalate Attacks as Mayoral Race Enters Final Month
With less than a month before the June 22 primary, Democratic candidates... - Bernie Madoff, infamous Ponzi schemer, has died
